http://www.rubiustx.com
Rubius Therapeutics, Inc. Company Intro
Rubius Therapeutics | Red Cell Therapeutics™? | Home Rubius Therapeutics is realizing the power of red by creating red blood cells and transforming them into cellular medicines. Learn More.
Industry
Healthcare
Rubius Therapeutics, Inc. Headquaters
399 Binney Street
Cambridge,02139
United States
Rubius Therapeutics, Inc. Share price
17 May 2023 13:50 GMT
$0.0190
-0.0 (-5.47 %)
Rubius Therapeutics, Inc. Market cap
$1.819 M
WMC RANKING
2023
Rubius Therapeutics, Inc. # 411
BiotechnologyLatest Rubius Therapeutics, Inc. News
20 Sep 2023
Avacta Group Plc Announces Management Changes ...
Prior to Rubius, Dr. Coughlin was with Tmunity Therapeutics Inc., where she served as Chief Medical Officer and was responsible for the development of...
20 Sep 2023
Avacta Group Share Chat. Chat About AVCT Shares. Join in the Conversation with Avacta Group Share Discussion.
20 September 2023. Avacta Group plc ("Avacta" or the "Group" or the "Company") Appointment of Dr. Christina Coughlin as a consultant
WMC Market Score
WMC Market to Revenue Score
Rubius Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Rubius Therapeutics, Inc. | USD | $0 | $158,515 | $-161,575 | $18M | 411 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Rubius Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Rubius Therapeutics, Inc. Post vs Top 4 Industry Competitors
Rubius Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Rubius Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Rubius Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Rubius Therapeutics, Inc. | 0 | 0.72 | 0.05 | 0 | 0 | 0 | 0.33 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
